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Abstract
Background:  Chronic  active  EBV  infection  (CAEBV)  of  T-cell  or  NK-cell  type  is  an  EBV+  polyclonal,
oligoclonal  or  often  monoclonal  lymphoproliferative  disorder  (LPD)  recognized  as  representing
the spectrum  of  EBV-associated  T-cell  and  NK-cell  LPD  with  different  clinical  presentations;
one systemic  and  two  cutaneous  disorders  including  hydroa  vacciniforme-like  T-cell  LPD  and
mosquito  bite  hypersensitivity.  The  systemic  form  of  the  disease  is  characterized  by  fever,
persistent  hepatitis,  hepatosplenomegaly  and  lymphadenopathy,  which  shows  varying  degrees
of clinical  severity  depending  on  the  immune  response  of  the  host  and  the  EBV  viral  load.
Case reports: We  described  the  clinicopathological  ﬁndings  of  two  children  with  CAEBV  with  a
brief review  of  the  literature.
Conclusions:  Recognition  of  the  disease  is  important  for  adequate  management  of  the  patient.
EBV analysis  should  be  included  in  the  principal  diagnostic  tests  for  febrile  children.
© 2015  Hospital  Infantil  de  México  Federico  Gómez.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
PALABRAS  CLAVE
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Resumen
activa;
Linfocitosis  de  células
NK;
Introducción:  La  infección  crónica  activa  (CA)  de  células  T  o  células  tipo  NK  por  virus  de
Epstein-Barr  (VEB)  es  un  desorden  linfoproliferativo  (DLP)  VEB+  policlonal,  oligoclonal  o,  fre-
cuentemente,  monoclonal  reconocido  como  representación  del  espectro  del  DLP  de  células
n  VEB  que  tiene  diversas  presentaciones  clínicas:  un  padecimiento
e  incluyen  el  DLP  de  células  T  que  semeja  hidroa  vacciniforme  y  la
ura  de  mosquito.  Los  síntomas  de  la  enfermedad  sistémica  incluyenHipersensibilidad  por
picadura  de  mosquito
T y  células  NK  asociado  co
sistémico  y  dos  cutáneos  qu
hipersensibilidad  por  picad∗ Corresponding author.
E-mail addresses: yhko310@skku.edu, younghyeh.ko@samsung.com (Y.-H. Ko).
ttp://dx.doi.org/10.1016/j.bmhimx.2015.12.003
665-1146/© 2015 Hospital Infantil de México Federico Gómez. Published by Masson Doyma México S.A. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ﬁebre,  hepatitis  persistente,  hepatoesplenomegalia  y  linfadenopatías  que  muestran  diferente
grado de  severidad  clínica,  dependiendo  de  la  respuesta  inmune  del  hospedero  y de  la  carga
viral del  VEB.
Casos  clínicos:  Se  describen  los  hallazgos  clínico-patológicos  de  dos  nin˜os  con  CAVEB  y  una  breve
revisión de  la  literatura.
Conclusiones:  Es  importante  reconocer  esta  enfermedad  para  proporcionar  el  manejo  adecuado
al paciente.  El  análisis  de  VEB  debería  incluirse  como  una  de  las  principales  pruebas  diagnósticas
en nin˜os  con  ﬁebre.
© 2015  Hospital  Infantil  de  México  Federico  Gómez.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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symptoms  and  signs  since  he  was  5  years  old.  Birth  weight1. Introduction
Chronic  active  Epstein-Barr  virus  infection  (CAEBV)  is  a  clin-
ical  term  initially  deﬁned  by  Straus  as  a  disease  related
to  chronic  or  persistent  infection  of  EBV.  Suggested  crite-
ria  for  diagnosing  severe  chronic  EBV  infection  includes
the  following:  1)  severe  illness  of  >6  months  duration  that
began  as  primary  EBV  infection  and  is  associated  with  grossly
abnormal  EBV  antibody  titers  [IgG  to  viral  capsid  antigen
(VCA)  =  ∼1:5120;  antibody  to  early  antigen  (EA)  =  ∼1:640;
or  antibody  to  EBV  nuclear  antigen  (EBNA)  <2],  and  2)
histological  evidence  of  major  organ  involvement  such  as
interstitial  pneumonia,  hypoplasia  of  some  bone  marrow
elements,  uveitis,  lymphadenitis,  persistent  hepatitis  or
splenomegaly,  and  3)  detection  of  increased  quantities  of
EBV  in  affected  tissues  by  anticomplementary  immuno-
ﬂuorescence  for  EBNA  or  nucleic  acid  hybridization1.  In
early  reports,  the  cellular  lineage  of  EBV-infected  cells
has  not  drawn  attention;  however,  subsequent  reports  doc-
umented  that  EBV  mainly  exists  in  T-cells2,3 but  not  in
B-cells,  as  revealed  by  dual  staining  immunoﬂuorescence
analysis3.  Just  as  the  accumulation  of  clinical  and  labora-
tory  data  for  CAEBV,  it  has  been  recognized  that  clinical
and  laboratory  ﬁndings  of  CAEBV  are  of  a  broader  spec-
trum  than  initially  thought.  Because  individual  cases  do  not
fulﬁll  the  diagnostic  criteria  initially  proposed,  Kimura  and
colleagues  modiﬁed  the  diagnostic  criteria  for  CAEBV  as  fol-
lows:  (1)  illness  ≥3  months  duration  [EBV-related  illness
or  symptoms  including  fever,  persistent  hepatitis,  exten-
sive  lymphadenopathy,  hepatosplenomegaly,  pancytopenia,
uveitis,  interstitial  pneumonia,  hydroa  vacciniforme  (HV),
and  hypersensitivity  to  mosquito  bites  (HMB)];  (2)  increased
amounts  of  EBV  DNA  or  grossly  abnormal  levels  of  EBV
antibodies,  for  instance,  detection  of  EBV  DNA  in  tissues
or  peripheral  blood  by  Southern  blot  hybridization;  EBV-
encoded  small  RNA-1-positive  cells  in  affected  tissues  or
peripheral  blood,  >102.5 copies  of  EBV  DNA/g of  DNA  of
peripheral  blood  mononuclear  cells;  and  grossly  abnormal
levels  of  EBV  antibodies  (anti-VCA  IgG  titers  ≥5120  or  anti-
EA  IgG  titers  ≥640),  and  (3)  no  evidence  of  previous  immuno-
logical  abnormalities  or  other  recent  infection  that  might
explain  the  observed  condition.4
Based  on  the  accumulated  data,  CAEBV  of  T-cell  or
NK-cell  type  has  been  recently  deﬁned  as  a  systemic
EBV+  polyclonal,  oligoclonal  or  often  monoclonal  lym-
phoproliferative  disorder  (LPD)  characterized  by  fever,
w
v
oersistent  hepatitis,  hepatosplenomegaly  and  lymphadeno-
athy,  which  shows  varying  degrees  of  clinical  severity
epending  on  the  immune  response  of  the  host  and  the  EBV
iral  load.5,6
CAEBV  is  often  accompanied  by  cutaneous  lesions  such
s  severe  mosquito  bite  allergy  and  hydroa-vacciniforme
HV)-like  T-cell  lymphoproliferative  disease.  Mosquito  bite
ypersensitivity  (or  mosquito  bite  allergy,  MBH)  is  a  unique
utaneous  manifestation  of  CAEBV  infection  characterized
y  abnormally  intense  local  reaction  at  arthropod  bite  area
ssociated  with  systemic  symptoms  and  signs  like  fever,  lym-
hadenopathy  and  liver  dysfunction.  EBV  genome  is  mainly
ound  within  NK  cells  of  peripheral  blood  of  MBH  patients
ho  often  show  NK  cell  lymphocytosis.7--10
HV-like  LPD  is  an  EBV-associated  polyclonal,  oligoclonal,
r  monoclonal  cutaneous  T-cell  lymphoproliferative  dis-
ase  characterized  by  recurrent  vesiculopapular  eruptions,
ainly  on  the  face  and  arms.  It  shows  a  broad  spec-
rum  of  clinical  aggressiveness  and  usually  a  long  clinical
ourse  with  risk  to  develop  systemic  lymphoma.  As  the
isease  progresses  patients  develop  severe  and  extensive
kin  lesions  with  systemic  symptoms  including  fever,  hep-
tosplenomegaly  and  lymphadenopathy.  Classic  HV,  severe
V  and  HV-like  T-cell  lymphoma  constitute  a continuum
pectrum  of  EBV-associated  HV-like  LPD.5,11--14
Recently,  the  three  disorders  indicated  above  have  been
ecognized  as  representing  the  spectrum  of  EBV-associated
-cell  and  NK-cell  LPD  with  different  clinical  presentations;
ne  systemic  and  two  cutaneous  disorders  including  HV-like
-cell  LPD  and  MBH.14
.  Case reports
he  patients  described  in  the  following  two  case  reports
epict  typical  clinical  manifestations  of  CAEBV  with  MBH  in
hildren.  Case  2  was  reported  previously.15
.1.  Case  1
 15-year-old  Korean  boy  was  admitted  to  the  hospital  with
hronic  intermittent  dermatological  and  various  systemicas  normal  and  adequate  for  gestational  age.  At  a  recent
isit  to  a  pediatric  department,  he  showed  adequate  height
f  163.7  cm  for  his  age,  but  a  low  body  weight  of  39.6  kg.
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pigure  1  Case  1.  (A)  Mosquito  bite  hypersensitivity  at  12  yea
f age.  (C)  Similar  skin  lesion  in  the  neck.
At  5  years  old,  fever,  cough,  and  abdominal  disten-
ion  suddenly  developed.  White  blood  cell  count  was
2.1  ×  103/l  (lymphocytes  70%,  segmented  neutrophils
1%,  eosinophils  1%,  and  monocytes  8%).  Qualitative  ﬂu-
rescent  antinuclear  antibody  was  negative.  Following  a
linical  diagnosis  of  intestinal  perforation,  he  underwent  a
ubtotal  colectomy  and  ileostomy.  One  month  after  surgery,
ymphocyte  subset  counts  by  ﬂow  cytometry  showed  low
umbers  of  B-  and  T-cells,  with  markedly  increased  NK-cells
CD16  +  CD56+  =  68%,  normal  range  5.6-31%);  1,579/l (nor-
al  range  100-430/l).
He  was  subsequently  hospitalized  ﬁve  times  in  3  years
ecause  of  acute  pharyngotonsillitis,  upper  respiratory
nfection,  bronchiolitis,  and  pneumonia  and  experienced
ecurrent  fever  two  or  three  times  per  month.  At  10  years
ld,  he  was  hospitalized  because  of  upper  respiratory  tract
nfection.  Splenomegaly  of  10.76  cm  was  found  inciden-
ally  during  workup.  From  the  age  of  10,  intense  skin
esponses  manifested  at  mosquito-  or  other  bug-bitten  sites
hat  were  characterized  by  an  initial  bullous  change  fol-
owed  by  ulceration,  crust  formation,  and  scarring  with
igmentation  (Fig.  1).  Most  lesions  were  <1  cm  in  diameter
nd  were  frequently  accompanied  by  fever.  Such  cutaneous
esions  tended  to  occur  in  the  summer  and  on  the  upper
nd  lower  extremities.  Laboratory  tests  performed  at  the
ime  of  severe  mosquito  bite  allergy  showed  mild  elevation
f  aspartate  transaminase/alanine  transaminase  (AST/ALT)
ith  signiﬁcant  elevation  of  alkaline  phosphatase  (200  U/l)
nd  globin  (4.5  to  4.8  g/dl).
A  skin  biopsy  obtained  from  a  lesion  was  reported  as
ndicating  a  possibility  of  Sweet’s  syndrome.  Abdominal
onography  indicated  splenomegaly.  Differential  counts  of
eripheral  blood  showed  low  B-  and  T-cell  populations,  and
K-cell  lymphocytosis  [CD16  +  CD56+  =  62%;  3520/l (normal
ange  =  70-1200/l)].  The  serum  IgE  level  was  increased  to
0,370  U/ml  although  no  speciﬁc  response  to  various  aller-
en  stimuli  was  identiﬁed.  Despite  no  proven  family  history, clinical  impression  of  hyper-IgE  syndrome  was  made  as
he  ﬁrst  differential  diagnosis.  A  genetic  study  that  included
TAT3  sequencing  was  performed  but  failed  to  ﬁnd  the
xpected  mutation.  In  considering  the  clinical  course  and
r
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bage.  (B)  Erythematous  scaly  skin  lesion  of  the  face  at  15  years
K  lymphocytosis,  CAEBV  or  EBV-associated  lymphoprolife-
ative  disease  was  considered  as  other  differential  diagnoses
nd  relevant  tests  were  established.
Serologic  tests  showed  positivity  of  EBV  VCA-IgG,  EBV-
arly  antigen,  and  negativity  of  EBV  VCA  IgM.  Using  a  whole
lood  sample,  real-time  quantitative  PCR  for  EBV  DNA  was
erformed  to  determine  the  viral  load  in  blood  (11,450
opies/5  l of  whole  blood).  Subsequently,  he  underwent  a
egular  checkup  of  viral  genome  copy  number,  which  was
ound  to  be  consistently  high,  ranging  from  212.5  copies/l
o  1,562  copies/l of  whole  blood.  His  skin  problem  associ-
ted  with  mosquitoes  or  bugs  had  occurred  intermittently
ver  since,  while  intermittent  episodes  of  febrile  illness
evoid  of  skin  lesion  had  also  persisted.  Nonspeciﬁc  skin
roblem  persisted  for  15  months.  Physical  examination
evealed  erythematous  to  brownish  scaly  patches  with  yel-
owish  crusts  on  his  face,  neck,  scalp,  upper  chest,  and  upper
ack.  He  was  treated  with  topical  steroids  and  oral  anti-
istamines  under  impression  of  seborrheic  dermatitis  for
1  months  (Fig.  1).  Two  months  prior  to  examination,  his
ymptoms  became  aggravated  and  he  visited  a  dermatology
linic.  Two  skin  biopsies  from  his  face  and  neck  were  taken
nd  EBV  in  situ  hybridization  was  performed.  The  biopsies
howed  increased  lymphoplasma  cells  in  the  superﬁcial  and
eep  dermis  with  occasional  periadnexal  distribution.  There
as  no  clear  atypia  in  most  lymphoid  cells.  Immunohisto-
hemistry  showed  many  CD56+  lymphoid  cells.  There  were
umerous  lymphocytes  showing  a  nuclear  positive  reaction
o  EBER  in  situ  hybridization.  Retrospectively,  EBER  in  situ
ybridization  was  applied  to  both  the  skin  biopsy  of  the
ower  leg  taken  for  severe  mosquito  bite  allergy  and  that  of
he  perforated  intestine  resected  10  years  ago  (Fig.  2).  Many
ymphoid  cells  with  a  positive  reaction  were  identiﬁed,  not
nly  in  the  skin  but  also  in  the  intestinal  wall  and  sinusoids
f  the  liver  and  lymph  node,  which  conﬁrmed  CAEBV  infec-
ion  with  mosquito  bite  allergy  and  NK  lymphocytosis.  The
atient  was  treated  conservatively.  Two  years  later  he  was
eadmitted  because  of  hemophagocytic  lymphohistiocytosis
HLH).  He  was  treated  according  to  the  HLH-2004  treatment
uideline16 and  responded  transiently,  but  later  developed
owel  perforation  and  died  of  sepsis.
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Figure  2  Case  1.  (A)  Perforated  colon  at  5  years  of  age.  (B)  Microscopic  ﬁndings  show  acute  and  chronic  inﬂammation  with
granulation tissue.  (C)  EBER  in  situ  hybridization  reveals  EBV-positive  lymphocytes.  (D)  EBV-positive  lymphocytes  are  positive  for
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2.2.  Case  2
A  10-year-old  Korean  boy  presented  to  the  Department
of  Dermatology  complaining  of  intense  skin  reactions  at
mosquito  bite  sites.  He  exhibited  multiple  scattered,
punctuated  ulcerations  on  bilateral  lower  extremities.  In
addition  to  the  marked  cutaneous  reaction,  he  also  endorsed
systemic  symptoms  including  fever  following  insect  bites
throughout  his  childhood.  A  skin  biopsy  was  taken  and  local
treatment  for  the  lesion  was  administered  without  further
systemic  evaluation.  At  16  years  of  age,  the  patient  admit-
ted  with  a  palpable  mass  located  on  the  left  neck  of  2  3
weeks’  duration.  On  physical  examination,  a  conglomer-
ate  of  large  lymph  nodes  was  present  in  the  left  neck,  the
largest  of  which  measured  7  ×  5  cm.  Due  to  his  history  of
skin  lesions,  careful  inspection  of  his  legs  was  performed,
revealing  multiple  shallow  ulcers  with  healing  scars.  Com-
puted  tomography  and  positron  emission  tomography  scan
showed  multiple  poorly  enhancing  and  variable  sized  homo-
geneous  lymph  nodes  involving  the  left  cervical  region  and
bilateral  inguinal  areas.  In  addition,  there  were  multifo-
cal  lesions  demonstrating  increased  2-deoxy-2-[ﬂuorine-18]
ﬂuoro-D-glucose  uptake  in  the  skin  and  subcutaneous  layer
of  bilateral  cheeks  and  buttocks.  On  hematologic  exam-
ination,  blood  cell  counts  and  lactic  acid  dehydrogenase
level  were  within  normal  limits.  Anti-VCA  IgG,  anti-EA  and
anti-EBNA  IgG  were  positive  and  anti-VCA  IgM  was  negative.
The  EBV  DNA  copy  number  was  529.8  copies/l  of  whole
blood.
h
p
b
aLymph  node  biopsy  was  performed  revealing  widen-
ng  of  the  paracortex  with  inﬁltration  of  heterogeneous
nﬂammatory  cells  including  small  lymphocytes,  histiocytes
nd  many  eosinophils.  The  inﬂammatory  inﬁltrate  was
unctuated  by  scattered  large  mononuclear  or  multinuclear
eed-Sternberg  (RS)-like  atypical  cells,  which  had  large
osinophilic  nucleoli  and  thick  nuclear  membrane.  Using
mmunohistochemical  study,  the  RS-like  cells  demonstrated
 strong  membranous  stain  for  CD30  and  perinuclear  staining
or  CD15  and  were  positive  for  PAX-5  and  LMP-1,  but  negative
or  CD20,  CD3,  and  EBNA-2.  Atypical  mononuclear  and  mult-
nuclear  RS-like  cells  showed  a  positive  signal  by  EBER  in  situ
ybridization.  Aside  from  the  RS-like  cells,  many  small  lym-
hocytes  scattered  in  the  background  were  also  positive  for
BER  in  situ  hybridization.  No  abnormal  ﬁndings  were  noted
n  the  bone  marrow  biopsy  except  for  a  few  EBV-positive
mall  lymphocytes.  The  skin  biopsy  from  the  region  of
osquito-bite  allergy  in  2002  was  retrospectively  reviewed,
evealing  severe  necrosis  of  the  epidermis  and  upper  dermis.
here  was  inﬁltration  of  small  lymphocytes,  histiocytes  and
any  eosinophils  around  the  blood  vessels  and  hair  follicles
nd  the  blood  vessel  lumens  were  often  obliterated  by  red
lood  cells  (RBCs)  and  ﬁbrin.  Immunohistochemical  analysis
evealed  that  the  inﬁltrating  cells  were  heterogeneous  in
heir  lineage;  some  were  positive  to  CD3  and  CD4  or  CD8
elper  or  cytotoxic  T  cells,  whereas  others  were  NK  cells
ositive  for  CD56.  Many  EBV-positive  cells  were  documented
y  EBER  in  situ  hybridization.  The  diagnosis  of  chronic
ctive  EBV  infection  with  mosquito  bite  hypersensitivity
14
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Table  1  Clinical  and  laboratory  ﬁndings  of  13  patients  with  chronic  active  EBV  infection  related  disease.
Patient  Age  at
admission
Sex  Diagnosis  Clinical  ﬁndings  at  presentation
Fever  Abnormal
LFT
HSM  LD  Non-speciﬁc
skin  lesion
MBH  NK
lymphocytosis
Others  Onset  (yrs
of  age)
1  10  M  CAEBV  +  +  +  +  --  --  UK  --  8
2 10  M  CAEBV  +  +  +  +  --  --  --  Bowel  perforation,
cytopenia,  HLH
9
3 14  F  HV-like  T-LPD  +  --  --  --  --  --  UK  IgA  nephropathy  Infancy
4 16  F  HV-like  T-LPD  +  +  --  +  +  --  UK  --  UK
5* 10  M  CAEBV  with  MBH  +  +  --  +  --  +  UK  --  10
6 16  M  CAEBV  with  MBH  +  +  +  UK  --  +  UK  Eye  angioedema  14
7* 16  M  CAEBV  with  MBH  +  +  +  --  +  +  +  Bowel  perforation,
hypereosinophilia,
HLH
5
8 24  M  CAEBV  with  MBH  +  +  UK  UK  --  +  UK  HLH,  nausea,
vomiting
Since
childhood
9 22  M  CAEBV  +  +  +  +  --  --  +  Paroxysmal
dyskinesia,  severe
oral  ulcer,
pneumonia,
thrombocyto-
penia,
HLH
20
10 27  F  CAEBV  +  +  +  --  --  --  UK  Headache,
pancytopenia,
lung  inﬁltration
3  months
ago
11 34  M  CAEBV  +  +  +  --  --  --  UK  Cytopenia,  HLH,
myalgia
33
12 43  M  CAEBV  +  +  +  +  --  --  UK  --  42
13 58  F  CAEBV  +  +  +  +  --  --  +  Myalgia,  blurred
vision
57
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Table  1  (Continued)
Patient TCR  Gene
rearrangement
EBV  load  in  whole
blood/Serology
Treatment FU  (yrs) Outcome  Causes  of  death
1  Monoclonal  1143  copies/5  l HLH  2004  protocol 3  Died  Acute  hepatic  failure,  HLH,
hepatic  encephalopathy
2 polyclonal  7.5  copies/5  l Allo  PBSCT 3  Alive
3 polyclonal  ND  CHOP  13  Died  Sepsis,  EBV+  T-cell  lymphoma
at larynx
4 polyclonal  ND  None  5  Alive
5* polyclonal  EA+,  VCA  IgM+,  35  copies/5  l ABVD  13  Alive
6 ND  7,000  copies/l/EA+,  VCA  IgM+  None  2.5  Alive
7* polyclonal  1,562  copies/5  l,  VCA  IgM/IgG
(--/+),  EA+
EBNA+
HLH  2004  protocol  11  Died  HLH,  hematochezia
8 ND  ND  IMVP16  10  Died  ANKL
9 polyclonal  150  copies/5  l  CHOP,  ICE/DEXA  2  Died  HLH
10 polyclonal  6936  copies/5  l  UK  1.5/lost  to  FU  Alive
11 ND  17,230  copies/5  l
VCA  IgG+,  -VCA  IgM-
EA+,  EBNA+
None  1  Died  UK
12 ND  EA+,  VCA  IgG+,  EBNA+  None  0.5  Died  HLH
13 ND  326.40  copies/5  l  CVP  lost  to  FU  Alive
5*: Case 2, 7*: Case 1.
MBH, mosquito-bite hypersensitivity; LFT, liver function test; LPD, lymphoproliferative disease; FU, follow up; ND, not done; ANKL, aggressive NK cell leukemia; HSM, hepatosplenomegaly;
LD, lymphadenopathy; PBSCT, peripheral blood stem cell transplantation; HV, hydroa vacciniforme; HLH, hemophagocytic lymphohistiocytosis; UK, unknown.
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1
suka M, et al. Pathogenic link between hydroa vacciniforme
and Epstein-Barr virus-associated hematologic disorders. Arch6  
nd  polymorphic  lymphoproliferation  simulating  Hodgkin’s
ymphoma  was  made.  The  patient  was  treated  with  ABVD
Adriamycin,  Bleomycin,  Vinblastin,  and  Dacarbazine) for
ix  cycles  with  complete  remission.  Currently  he  remains
ree  of  disease  for  7  years  after  treatment.
. Discussion
he  clinical  course  of  CAEBV  patients  depends  on  the  bal-
nce  between  EBV-related  factors  and  host  immune  function
nd  can  be  smoldering,  progressive,  or  aggressive.  Some
atients  develop  EBV+  T/NK  cell  lymphoma/leukemia.4,17
rom  1998  to  2014,  13  patients  aged  10--58  years  (median
ge  22  years,  nine  males  and  four  females)  were  diag-
osed  with  CAEBV  disease  at  Samsung  Medical  Center,
orea  (Table  1).  The  common  clinical  ﬁndings  included
ever  (13/13),  hepatosplenomegaly  (9/12),  lymphadeno-
athy  (7/11),  NK  lymphocytosis  (3/4),  MBH  (4/13),  and
V-like  LPD  (2/13).  Some  patients  presented  with  bowel
erforation,  chorea,  or  brain  infarction.  In  the  median
ollow-up  of  36  months,  seven  patients  (54%)  died  of  the
isease,  two  patients  (15%)  had  persistent  disease,  and  two
atients  (17%)  were  free  of  disease.  Two  patients  were  lost
o  follow-up.  The  causes  of  death  were  hemophagocytic  syn-
rome  and  organ  failure  in  four  patients,  EBV-positive  T  cell
ymphoma  in  one  patient,  and  aggressive  NK  cell  leukemia
n  one  patient.  B-lineage  lymphoproliferation  mimicking
odgkin’s  lymphoma  as  seen  in  case  2  is  rare  but  has  been
reviously  reported.18
CAEBV  infection  is  almost  always  accompanied  by  vary-
ng  degrees  of  lymphoproliferation.  The  clonality  of  EBV
nd  EBV-infected  T-  or  NK-cells  varies  and  may  be  poly-
lonal,  oligoclonal,  or  monoclonal.  As  the  disease  progresses
rom  polyclonal  lymphoproliferation  to  monoclonal  disease,
istological  atypia  increases.  Ohshima  et  al.  proposed  the
ategorization  of  CAEBV  into  three  groups----polymorphous
nd  polyclonal,  polymorphous  and  monoclonal,  or  monomor-
hic  and  monoclonal-based  on  clonality  and  histological
hanges.19 In  the  series  reported  by  Ohshima  et  al.,  8/48
atients  with  CAEBV  infection  were  polyclonal  for  TCR
ene  rearrangement  and  the  inﬁltrated  cells  displayed
olymorphic  histomorphology;  15  patients  showed  poly-
orphic  morphology  and  biclonal  or  monoclonal  TCR  gene
earrangement;  and  25  patients  showed  monomorphic  his-
omorphology  and  monoclonal  TCR  gene  rearrangement.
atients  with  the  monomorphic  and  monoclonal  type  of
AEBV  infection  had  poorer  prognoses  than  those  with
olymorphic  polyclonal  or  polymorphic  monoclonal  dis-
ase.  The  survival  of  the  polymorphic/polyclonal  and
olymorphic/monoclonal  groups  did  not  differ  signiﬁcantly.
onomorphic/monoclonal  groups  of  CAEBV  by  Ohshima
t  al.  may  correspond  to  systemic  T-cell  LPD  according  to
he  2008  WHO  classiﬁcation.20
In  summary,  CAEBV  is  a  rare  EBV-associated  LPD  of  pre-
ominantly  T-cell  or  NK-cell  lineage  with  a  broad  spectrum
f  clinical  presentation.  Recognition  of  the  disease  is  impor-
ant  for  adequate  management  of  the  patient.  EBV  analysis
hrough  real-time  PCR  of  a  blood  sample  or  EBV  in  situ
ybridization  in  the  affected  tissue  is  important  to  avoid
verlooking  these  patients  and  should  be  included  in  the
rincipal  diagnostic  tests  for  febrile  children.
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